Pieris Pharma (PIRS) Reports Q4 Loss Per Share of $0.07

Pieris Pharma (NASDAQ: PIRS) reported Q4 EPS of ($0.07), versus ($0.21) reported last year. Revenue for the quarter came in at $2.14 million, versus $3.27 million reported last year.

For earnings history and earnings-related data on Pieris Pharma (PIRS) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c